Omkar Pharmachem Q2 FY27 reports Rs. 0.39 lakhs net profit from other operating income
RESULTS
▼ Concern Flagged
HIGH RISK
📅 Filed on BSE: 14 Nov 2026, 05:22 PM IST · BSE ID: 72d60c5f-f623-4856-a681-170e4043c6c1
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a net profit of Rs. 0.39 lakhs for the quarter, with no sales from core operations.
🤖 AI Summary
- Board of Directors approved unaudited financial results for Q2 FY27 and half year ended September 30, 2026.
- Company reported a net profit of Rs. 0.39 lakhs for the quarter ended September 30, 2026.
- Net sales/income from operations were Rs. 0.00 lakhs; total income primarily from other operating income of Rs. 9.00 lakhs.
- Total expenses for the quarter stood at Rs. 8.61 lakhs, including employee benefits of Rs. 6.34 lakhs.
- Basic and diluted Earnings Per Share (not annualised) was Rs. 0.0039 for Q2 FY27.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Net Sales/Income from Operations (Q2 FY27)
0.00 Rs. in lakhs
Other Operating Income (Q2 FY27)
9.00 Rs. in lakhs
Profit(Loss) for the period (Q2 FY27)
0.39 Rs. in lakhs
Total Comprehensive Income for the period (Q2 FY27)
0.39 Rs. in lakhs
Total Assets (as at 30-09-2026)
3667.59 Rs. in lakhs
Total Equity (as at 30-09-2026)
3663.36 Rs. in lakhs
Net Cash Flow from Operating Activities (Half year ended 30-09-2026)
(5.26) Rs. in lakhs
🏢 How This Affects the Company
The company did not report any Net Sales/Income from Operations for Q2 FY27, indicating no revenue generation from core business activities during the period.
Profit for Q2 FY27 was Rs. 0.39 lakhs, derived entirely from Other Operating Income, suggesting a reliance on non-core income streams. The company reported negative cash flow from operating activities for the half year ended September 30, 2026, at (5.26) lakhs.
The absence of Net Sales/Income from Operations raises concerns about the sustainability of revenue generation and operational viability from its primary business activities.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the absence of core revenue and the reported net profit of Rs. 0.39 lakhs for Q2 FY27.
🔍
Management Signal
The approval of results with no core operational sales signals management's continued operation despite a lack of primary business revenue.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for any change in net sales/income from operations.
Updates on business strategy to generate core operational revenue.
Any further disclosures regarding other operating income sources.
HIGH RISK
The company reported no core operational sales for Q2 FY27, raising concerns about business sustainability.
💡 Investor Takeaway
Omkar Pharmachem Ltd's Q2 FY27 unaudited financial results show a net profit of Rs. 0.39 lakhs. Net sales remained at Rs. 0.00 lakhs, with income primarily from Other Operating Income of Rs. 9.00 lakhs. Half-year profit before tax decreased to (0.62) lakhs from Rs. 10.38 lakhs YoY.
⚖️ Strengths & Concerns
⚠️ Concerns
- Net Sales/Income from Operations was Rs. 0.00 lakhs for Q2 FY27, indicating a lack of revenue from core business activities.
- Profit before Tax for the half year ended September 30, 2026, was (0.62) lakhs, a decrease from Rs. 10.38 lakhs in the prior comparable half-year period.
📅 Company Track Record
Omkar Pharmachem's previous Q2 FY27 filing (2026-11-14) also reported a net profit of Rs. 0.39 lakhs with no core sales. The Q1 FY27 results (approved via board meeting on 2026-08-06) similarly indicated limited operational activity.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Omkar Pharmachem's net profit in Q2 FY27?
Omkar Pharmachem Ltd reported a net profit of Rs. 0.39 lakhs for the quarter ended September 30, 2026 (Q2 FY27).
Did Omkar Pharmachem report any sales from operations in Q2 FY27?
No, Omkar Pharmachem Ltd reported Net Sales/Income from Operations of Rs. 0.00 lakhs for Q2 FY27.
What was Omkar Pharmachem's total income for Q2 FY27?
The company's Net Total Income for Q2 FY27 was Rs. 9.00 lakhs, primarily driven by Other Operating Income.
What was the cash flow from operating activities for Omkar Pharmachem in the half year ended September 30, 2026?
Omkar Pharmachem Ltd reported a Net Cash Flow from Operating Activities of (5.26) Rs. in lakhs for the half year ended September 30, 2026.
Questions based on this BSE filing only. For information purposes.